Introduction is not clear whether the association with heterochromatin is the cause or the consequence of silencing. Numerous studies have demonstrated that transcrip-
Once established, the silent state is stably inherited, tion is controlled by the interaction of positive and but it can be antagonized by transcriptional activators. negative regulatory factors with specific DNA elements For example, in yeast, telomeric silencing of URA3 is flanking a gene. However, the eukaryotic genome is suppressed by binding of the transcriptional activator organized in a complex and heterogeneous structure PPR1 to its promoter (Aparicio and Gottschling, 1994). termed chromatin, which is not homogeneous for tranIn Drosophila, mutations in the GAGA factor, a transcripscriptional activity. For example, telomeres and centional activator involved in chromatin decondensation, tromeres are associated with more condensed, higherare dominant enhancers of position-effect variegation order chromatin structure, termed heterochromatin, (PEV) (Farkas et al., 1994) . Furthermore, silencing of which is thought to repress transcription (reviewed in transgenes in cultured mammalian cells and in mice is Wolffe and Pruss, 1996; Gregory and Horz, 1998; Kadosuppressed by inclusion of transcriptional enhancers in naga, 1998; Wakimoto, 1998) to suppress silencing relies on the integrity of core en-
Mutation of the 5HS2 Enhancer
In earlier experiments, we found that the erythroid enhancer motifs. At genomic integration sites where stable hancer 5ЈHS2 would suppress or retard silencing of a expression does not require the presence of an enreporter construct randomly integrated into the genome hancer, transgenes localize away from centromeric hetof cultured erythroid cells (Walters et al., 1996). We hyerochromatin in interphase nuclei, regardless of transpothesized that binding of transcriptional activators to gene activity or integrity of the enhancer. In contrast, at the enhancer is responsible for the observed ability of sites where stable expression requires an intact en-5ЈHS2 to suppress transgene silencing, and as a test of hancer, active transgenes localize away from centrothis hypothesis, we disrupted the core enhancer-binding meric heterochromatin when linked to a functional ensites in 5ЈHS2. 5ЈHS2 is a region of the ␤-globin LCR hancer. Enhancer mutations that impair the ability of that exhibits classical enhancer activity in transient the enhancer to suppress silencing also result in the assays and increases the probability of gene expression transgene remaining in close proximity to centromeric in colony assays and transgenic mice (for review, Hardiheterochromatin even before the transgene is silenced. son et al., 1997). The core enhancer, a 300 bp XbaI/ This mutational analysis demonstrates that the same HindIII fragment, has been shown to be sufficient for enhancer motifs are required for both suppression of the enhancer activity of 5ЈHS2 and the formation of the transgene silencing and localization of the transgene hypersensitive site (Caterina et al., 1991, 1994; Liu et away from centromeric heterochromatin. These mutaal., 1992). A group of motifs at the DNase I hypersensitive tions also dissociate transcriptional activity per se from core of 5ЈHS2 are binding sites for ubiquitous and hemasubnuclear location. In combination, these results sugtopoietic-specific transcription factors. We chose to disgest that transcriptional enhancers may maintain gene rupt these motifs because they have been previously expression by preventing localization of a gene near shown to be necessary for enhancer activity of 5ЈHS2 centromeric heterochromatin and/or by recruiting a in other assays and have been shown by in vivo footgene to a nuclear compartment in which transcription printing assays to be occupied by transcription factors is favored and stably heritable.
in the K562 erythroid cell line (Ikuta and Kan, 1991; Reddy and Shen, 1991). The structure of the mutants is Results shown in Figure 1 . These motifs can be bound by multiple factors, and there is some uncertainty regarding Experimental Strategy which factors occupy these sites in erythroid cells (reTo study the effects of transcriptional activators on gene viewed in Orkin, 1995) . GATA-1 is the major factor bindsilencing in cultured cells, we have made use of the ing to GATA motifs in erythroid cells. NF-E2 is a combifunctional reporter ␤-geo, a fusion of neo R and LacZ pound heterodimer, and the precise composition of the activities. Clones carrying integrated copies of ␤-geo species binding 5ЈHS2 in erythroid cells has not been constructs can be selected and expanded in G418, and established. CACC motifs in 5ЈHS2 may be occupied by as long as G418 selection is maintained, they are uni-EKLF or one of its homologs but can also be bound by formly ␤-gal positive. When G418 selection is removed, SP1. We introduced two single base mutations into the silencing of ␤-geo over time can be observed by serial tandem NF-E2-binding site; these mutations were previously shown to disrupt NF-E2 (but not AP-1) binding flow cytometric assays of ␤-gal. In experiments with this set of enhancer mutants, our goal was to establish (1) whether disruption of sites known to be critical for the classical enhancer effect of 5ЈHS2 also abolished its ability to suppress silencing, and (2) whether disruption of the enhancer affected the chromatin structure or subnuclear localization of a transgene.
Targeted Integration in the Genome of Cultured Cells
In order to compare the ability of the 5ЈHS2 enhancer and its derivative mutants to suppress silencing of transgene activity, it is necessary to integrate a series of test constructs into the same genomic site, because each site has a characteristic ability to silence an integrated transgene, and this ability varies widely. For this reason, we employed two general methods that use the Lox/Cre system of site-specific recombination to exchange components of single-copy transgenes at a We used both methods to place mutant enhancers at this event can be selected for with G418 and Gancyclovir and confirmed by Southern blot. integration sites derived by random integration. Constructs were placed in sites 1 and 6.2 using the single LoxP trap strategy and in site C30 by RMCE (Walters et al., 1999). Sites 6.2 and C30 were chosen because zero, when G418 selection is removed and all cells are the reporter construct at this site is silenced over a expressing. Silencing was assayed with FACS-Gal, a period of weeks, thus permitting us to assess the effects highly sensitive flow cytometric method that distinof altering components of the transgene. In contrast to guishes cells containing ␤-gal activity from those that sites 6.2 and C30, reporter silencing at site 1 is a rare do not (Fiering at al., 1991). event, even in the absence of an enhancer. Thus, site Consistent with our previous findings, inclusion of an 1 provides an opportunity to compare the mechanism enhancer in the transgene has a dramatic effect on the of silencing at sites in which transgene expression is time course of ␤-geo silencing at two of the three ranrelatively unstable (sites 6.2 and C30) with silencing at dom integration sites (Figure 3 ). In site 6.2, the transgene an integration site that is very permissive for expression.
containing the wild-type 5ЈHS2 remains active in more than 60% of the cells 20 weeks after removal of selection, whereas a transgene lacking 5ЈHS2 becomes silent Suppression of Silencing by 5HS2 Is Dependent on the Integrity of Core Enhancer Motifs in 90% of the cells within the same period. Similar results were obtained at site C30 (Figure 3 and Walters et al., The wild-type enhancer and its derivative mutants were integrated by Cre recombinase at the three sites dis-1999). Mutation of either the GATA sites (Figure 3) or the CACC sites (data not shown) alone has no effect on cussed above, in K562 erythroleukemia cells. The time course of ␤-geo silencing was followed from a time point the ability of 5ЈHS2 to suppress silencing. In contrast, None of the constructs integrated at site 1 showed any significant silencing of ␤-geo after 6 months without selection, regardless of the presence or absence of an enhancer. These results suggest that site 1 resides in a permissive chromatin environment, in which stable expression does not require strong activating elements in the transgene (see Discussion). which the transgene was either active or silent.
has the same degree of methylation as one with the 50 nuclei per construct were collected; distances between the transgene signal and the closest centromere wild-type enhancer, as long as both are in the same transcriptional state.
were measured and divided by the cell radius. We found that, at sites 6.2 and C30, the median distance is signifiChromatin structure analyses reveal that the silenced transgene [HS2␥(Ϫ)] is devoid of DNase I hypersensitive cantly smaller in silent cells than it is in expressing cells [ Figure 7 , compare HS2␥(Ϫ) with HS2␥(ϩ)]. This consites (HS) and inaccessible to restriction enzymes, indicating that it is in a "closed" chromatin configuration.
firms that silencing of the transgene at unstable sites is associated with repositioning of the transgene into In contrast, all transcriptionally active transgenes we examined contain a DNase I hypersensitive site at the closer proximity to centromeric DNA. In contrast to the repositioning of the transgene assopromoter ( Figure 5B ) and are accessible to restriction enzymes ( Figure 5C ). The HS at the core region of 5ЈHS2 ciated with silencing at sites 6.2 and C30, at site 1 the distance between the transgene and centromeres does is present only in transcriptionally active transgenes containing a functional enhancer (as reflected in its abilnot vary, regardless of the activity of the transcription unit (Figures 6 and 7 Figure 5C ). and C30), transgenes containing a wild-type enhancer The methylation and DNase I analyses show that the localize away from the centromeric probe when active process of silencing we observe is associated with a [Parent and HS2␥(ϩ)]. In addition, at these unstable stable alteration of the structure of the transgene. They sites, the silent state is associated with closer proximity also reveal that active transgenes have the same structo centromeric DNA. Consistent with these results, deleture regardless of the binding of transcription factors to tion of the enhancer and promoter from the parent conthe core enhancer. These results suggest that enhancerstruct integrated in site 6.2 results in close proximity bound activators increase the stability of expression of the silent transgene to centromeric heterochromatin and the stability of the active chromatin structure, but (Figure 7 , Deleted). At site 6.2, integration of a construct do not affect the structural phenotype of the active chrocarrying a wild-type enhancer into this silent promoter matin state. Thus, we sought evidence of some other trap results in transgene relocalization away from censtructural correlate of enhancer activity.
tromeres [ Figure 7 , compare Deleted construct and HS2␥(ϩ)]. These results suggest that the native locus at site 6.2 may reside close to centromeres in interphase Transgenes Can Be Silenced at a Distance from Centromeric Heterochromatin during Interphase nuclei, and that insertion of a wild-type enhancer and/ or an active transcription unit leads to the relocalization Since several reports have described a correlation between gene silencing and proximity to heterochromatin, of this locus away from heterochromatin. Based on their behavior in the transgene silencing we asked whether silencing of the ␤-geo transgene in K562 cells involves a change in its nuclear localization. assay described above (Figure 3) , the 5ЈHS2 enhancer mutants inserted at unstable sites 6.2 and C30 fall into We performed dual-color fluorescent in situ hybridization (FISH) using a human ␣ satellite probe detecting all two classes: (1) those that silence at the same rate as the wild-type enhancer (e.g., mGATA), and (2) those that human centromeres (red) and a plasmid probe covering the entire transgene (green). Analysis of metaphase silence as rapidly as in the absence of enhancer (e.g., mNF-E2 and m4sites). Thus, to determine whether relochromosomes demonstrates that the transgene at site 1, 6.2, or C30 is integrated on the long arm of three cation of the transgene away from centromeric heterochromatin is associated with the presence of the intact different chromosomes, in noncentromeric positions ( Figure 6A) . tive state, and not transcriptional activity per se, is the active transgene carrying the wild-type 5ЈHS2 localassociated with distance from the centromeric compartizes away from the heterochromatin probe, whereas the ment. Moreover, at unstable sites, the intact enhancer, transgene carrying a mutant enhancer is found in close and not transcription per se, is required for relocation proximity to centromeric heterochromatin even when of the active transgene away from centromeric heterotranscriptionally active. In contrast, at site 1, where chromatin. transgene activity is stable over long periods of time even in the absence of enhancer, the distance between the transgene and centromeres does not vary, whether Discussion it is active or silent. As expected, since the enhancer is not required for stable expression at that integration The results reported here provide evidence that core site, mutation of the NF-E2 motif does not affect the enhancer motifs are required to both suppress transgene stability of transgene expression and does not result in silencing and relocate the gene away from centromeric a change in the transgene's positioning relative to the heterochromatin during interphase. We previously recentromeric probe.
ported that transgene silencing in erythroid cells is supThus, at sites where an enhancer is required for stable pressed by the activity of the 5ЈHS2 enhancer (Walters expression (sites 6.2 and C30), active constructs conet al., 1996). Using a recombinase-mediated strategy to taining an intact 5ЈHS2 enhancer or an enhancer carrying assess multiple constructs at the same integration site, a neutral mutation localize away from centromeric hetwe now show that this suppression of silencing is assoerochromatin, whereas constructs carrying enhancer muciated with relocalization of the transgene away from tations that result in greater instability of the transgene centromeric heterochromatin. Moreover, we show that remain associated with the centromeres while still acboth suppression of silencing and relocalization require tive. However, at a site where the stable expression of a functional enhancer. Although transgene silencing at unstable expression the transgene is independent of an enhancer (site 1), 1998). However, in contrast to telomeric silencing, there is progressively silenced, and silencing of the TdT gene following induced differentiation of immortalized T lymis no direct evidence that association with centromeric heterochromatin is the cause of silencing, nor is there phocytes is reversible. The close proximity to centromeric heterochromatin of transgenes lacking a funcevidence of a requirement for a gene to localize away from heterochromatin in order to be transcriptionally tional enhancer may account for the instability of their expression over time. Conversely, localization of genes active.
away from centromeres may permit the reversal of their silent state.
Dissociation of Gene Activity and Subnuclear Location Our analysis of transgenes integrated in the stable ex-
Repositioning of the Transgene away from Centromeric Heterochromatin Requires pression site 1 demonstrates that a transgene can be inactive, methylated, in a "closed" chromatin conformaa Functional Enhancer Our findings, together with the examples discussed tion, but localize away from centromeric heterochromatin in interphase nuclei. The stable expression and activabove, suggest that a given locus can occupy different locations in the nucleus: in a centromeric or telomeric ity-independent positioning of the transgene at site 1 implies that some genomic sites are constitutively dissocompartment nonpermissive for stable gene expression, or in a compartment in which stable transcriptional ciated from centromeric heterochromatin. This may represent the default state of such loci in a specific lineage, activity is favored. Our results also present the novel observation that a functional enhancer can reposition a perhaps due to the presence in the locus of regulatory elements, such as enhancers or locus control regions sequence away from centromeric heterochromatin. At site 6.2, the promoterless construct, used as a (LCRs), which maintain the genes in the locus away from centromeric heterochromatin. trap for targeted reintegration, is in close proximity to centromeric heterochromatin. Insertion at this site of a We also found that a transgene can be associated with centromeric heterochromatin while transcriptionconstruct containing an intact enhancer results in the relocalization of the same locus away from heterochroally active (e.g., mNF-E2 in sites 6.2 and C30). In thymic lymphoma cell lines, the TdT gene remains away from matin. An enhancer lacking the NF-E2-binding sites, or all known core binding sites, fails to relocate the active centromeric sequences regardless of its activity (Brown et al., 1999). In both of these examples, the activity transgene away from centromeric heterochromatin. Localization of the transgene away from centromeres at states are transient and not clonally transmitted: the transgene in which enhancer activity has been disrupted site C30 also requires an intact NF-E2 site, as does stable expression of the transgene. We conclude that failure to target the gene to a transcription factor-rich the intact enhancer, and not transcription per se, medidomain. ates transgene localization away from centromeric hetPerhaps the simplest mechanism for the enhancererochromatin. Moreover, removal of the transgene from mediated relocalization of the transgene would be one the vicinity of centromeric heterochromatin by an intact in which transcriptional activators disrupt local interacenhancer is required for maintenance of the active state.
tions between the transgene and heterochromatin, perOur results provide evidence that enhancers may premitting it to move into the active compartment. Although vent a gene from localizing into proximity to heterothe exact nature of proteins found at the eukaryotic chromatin and/or "recruit" it to an active compartment, centromeres is not known, several proteins involved in thus preventing it from being silenced. In this respect, PEV, including HP1 ( (1996) . Genetic modification of heteroof the cell. For each population studied, at least three independent chromatic association and nuclear organization in Drosophila. Naseries of slides were assessed. At least 50 nuclei were counted, ture 381, 529-531. and the 10th, 25th, 50th (median), 75th, and 90th percentiles were calculated. p represents the p value for a pair of samples and was Dernburg, A.F., Broman, K.W., Fung, J.C., Marshall, W.F., Philips,
